PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 219 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,342,000 | +1.0% | 140,000 | -15.2% | 1.03% | -51.4% |
| Q3 2019 | $6,282,000 | +11.2% | 165,000 | +27.0% | 2.11% | +230.0% |
| Q2 2019 | $5,649,000 | -7.2% | 129,900 | -18.8% | 0.64% | -40.6% |
| Q1 2019 | $6,086,000 | -6.7% | 159,900 | +5.5% | 1.08% | +49.4% |
| Q4 2018 | $6,522,000 | -45.4% | 151,600 | -37.6% | 0.72% | -21.6% |
| Q3 2018 | $11,949,000 | +10.3% | 243,100 | -28.1% | 0.92% | +45.6% |
| Q2 2018 | $10,836,000 | -8.6% | 338,100 | -11.2% | 0.63% | -52.2% |
| Q1 2018 | $11,856,000 | -30.9% | 380,600 | +1.2% | 1.32% | -42.0% |
| Q4 2017 | $17,169,000 | -17.8% | 376,100 | -32.4% | 2.28% | -4.5% |
| Q3 2017 | $20,882,000 | +819.5% | 556,100 | +1068.3% | 2.39% | +323.8% |
| Q2 2017 | $2,271,000 | – | 47,600 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |